UK markets closed

MITSUBISHI UFJ FINL GRP (MFZ.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
4.46200.0000 (0.00%)
At close: 8:04AM CEST
Full screen
Previous close4.4620
Open4.4620
Bid0.0000 x 0
Ask0.0000 x 0
Day's range4.4620 - 4.4620
52-week range3.2000 - 5.0500
Volume1,000
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2021
    Business Wire

    Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2021

    TOKYO, July 12, 2021--Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the "Annual Report") with the U.S. Securities and Exchange Commission on July 9, 2021. The Annual Report includes MUFG’s audited consolidated financial statements prepared under U.S. GAAP as of and for the fiscal year ended March 31, 2021.

  • MUFG board beats back climate resolution as activists falter in Japan
    Reuters

    MUFG board beats back climate resolution as activists falter in Japan

    TOKYO (Reuters) -Mitsubishi UFJ Financial Group shareholders on Tuesday defeated a proposal for the bank to align its business with global targets on climate change, dealing a win for the board over investors pushing for more action on the environment. Activist investors in Europe and the United States trying to halt climate change have successfully compelled companies to divest their fossil fuel holdings but the tactic has failed in Japan so far. This is the fourth time since 2020 a so-called shareholder climate resolution has been defeated after being brought before a Japanese listed company.

  • Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing
    Business Wire

    Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing

    HERCULES, Calif., Jun 21, 2021--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its PREvalence™ ddPCR® SARS-CoV-2 Wastewater Quantification Kit, a sensitive, accurate, and cost-effective tool used to detect SARS-CoV-2 in a community’s wastewater.